SB 2212
  • Introduced
    Jan 14, 2021
  • Passed Senate
    Feb 11, 2021
  • Passed House
    Apr 09, 2021
  • Became Law
    Apr 26, 2021
SB 2212
North Dakota Senate Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
Relating to increased access to low-cost prescription drugs; to provide for a report; and to provide a contingent effective date. for an Act to provide for a legislative management study of prescription drug pricing, importation, and reference pricing.
Last Action See all actions
executive • Apr 27, 2021: Filed with Secretary Of State 04/23
Latest Bill Text See all bill texts
Enrollment

Summary

Comments on SB 2212

Tweets

Whip Lists

Sponsors
Votes
Feb 11, 2021, Senate
The question being on the final passage of the amended bill, which has been read, and has committee recommendation of DO PASS, the roll was called and there were 45 YEAS, 2 NAYS, 0 EXCUSED, 0 ABSENT AND NOT VOTING.
YES: 45
NO: 2
OTHER: 0
YES: 45

NO: 2

OTHER: 0
Sources
Apr 09, 2021, House
The question being on the final passage of the amended bill, which has been read, and has committee recommendation of DO PASS, the roll was called and there were 83 YEAS, 5 NAYS, 0 EXCUSED, 6 ABSENT AND NOT VOTING.
YES: 83
NO: 5
OTHER: 6
YES: 83

NO: 5

ABSENT: 6

Sources
Apr 20, 2021, Senate
The question being on the final passage of the amended bill, which has been read, the roll was called and there were 40 YEAS, 6 NAYS, 0 EXCUSED, 1 ABSENT AND NOT VOTING.
YES: 40
NO: 6
OTHER: 1
YES: 40

NO: 6

ABSENT: 1

Sources
Actions
  • Apr 27, 2021 | executive
    • Filed with Secretary Of State 04/23
  • Apr 26, 2021 | Senate
    • Signed by Governor 04/23
  • Apr 22, 2021 | Senate
    • Signed by President
    • Sent to Governor
  • Apr 22, 2021 | House
    • Signed by Speaker
  • Apr 21, 2021 | House
    • Conference committee report adopted
  • Apr 20, 2021 | House
    • Reported back from conference committee, placed on calendar (Senate accede)
  • Apr 20, 2021 | Senate
    • Reported back from conference committee, placed on calendar (Senate accede)
    • Conference committee report adopted
    • Second reading, passed, yeas 40 nays 6
  • Apr 16, 2021 | House
    • Conference committee appointed Rohr Tveit Dobervich
  • Apr 13, 2021 | Senate
    • Refused to concur
    • Conference committee appointed Anderson Lee Hogan
  • Apr 09, 2021 | Senate
    • Returned to Senate (12)
  • Apr 09, 2021 | House
    • Second reading, passed as amended, yeas 83 nays 5
  • Apr 06, 2021 | House
    • Amendment adopted, placed on calendar
  • Apr 05, 2021 | House
    • Reported back amended, do pass, amendment placed on calendar 13 1 0
  • Mar 09, 2021 | House
    • Bill Hearing, House Human Services, 03/09 9:00 AM, Room Pioneer - To provide for a legislative management study of prescription drug pricing, importation, and reference pricing
    • Committee Hearing 09:00
  • Feb 19, 2021 | House
    • Introduced, first reading, referred Human Services Committee
  • Feb 12, 2021 | House
    • Received from Senate
  • Feb 11, 2021 | Senate
    • Amendment adopted, placed on calendar
    • Second reading, passed, yeas 45 nays 2
  • Feb 10, 2021 | Senate
    • Reported back amended, do pass, amendment placed on calendar 5 1 0
  • Feb 08, 2021 | Senate
    • Committee Work, Senate Human Services, 02/08 11:00 AM, Room Sakakawea - Committee Work: Committee Work: Relating to increased access to low-cost prescription drugs
  • Jan 27, 2021 | Senate
    • Bill Hearing, Senate Human Services, 01/27 9:30 AM, Room Sakakawea - relating to increased access to low-cost prescription drugs
    • Committee Hearing 09:30
  • Jan 14, 2021 | Senate
    • Introduced, first reading, referred Human Services Committee
Bill Texts
Documents
Sources